Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Prognostic Microenvironment-Related Immune Signature via ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma
Huaide Qiu, Yongqiang Li, Shupeng Cheng, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Immunotherapy for Glioblastoma: Current Progress and Challenges
Miranda W. Yu, Daniela F. Quail
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 153
Glioblastoma Microenvironment and Cellular Interactions
Carmen Crivii, Adina Bianca Boşca, Carmen Stanca Melincovici, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1092-1092
Open Access | Times Cited: 45
A statistical and machine learning methodology to model rural depopulation risk and explore its attenuation through agricultural land use management
Daniel Jato‐Espino, Fernando Mayor-Vitoria
Applied Geography (2023) Vol. 152, pp. 102870-102870
Open Access | Times Cited: 21
A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma
Yuhan Sun, Alexander James Sedgwick, Yaseelan Palarasah, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 28
Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities
Amanda Johnson, John Laterra, Hernando López-Bertoni
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 21
From promise to progress: the dynamic landscape of glioblastoma immunotherapy
Muhammad Ijaz, Zia Ullah, Bilal Aslam, et al.
Drug Discovery Today (2024), pp. 104188-104188
Closed Access | Times Cited: 4
Comprehensive analysis and experiments identified ANXA1 as an unfavorable prognosticator in glioma
Yu Fan, Yanwen Chen, Xingda Run, et al.
Translational Oncology (2025) Vol. 53, pp. 102286-102286
Open Access
Annexin A’s Life in Pan-Cancer: Especially in Glioma Immune Cells
Yongqiang Wen, Wenhao Zhou, Z. Zhao, et al.
NeuroMolecular Medicine (2025) Vol. 27, Iss. 1
Closed Access
Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma
Huaide Qiu, Wei Tian, Yikang He, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 21
Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades
Saadia Ait Ssi, Dounia Chraa, Khadija El Azhary, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment
Tongzheng Chen, Wenbin Ma, Xin Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
ANXA1 as a Prognostic and Immune Microenvironmental Marker for Gliomas Based on Transcriptomic Analysis and Experimental Validation
Zhongxiao Lin, Min Wen, Enxing Yu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma
Xueqin Chen, Guotao Fu, Linglan Li, et al.
Journal of Trace Elements in Medicine and Biology (2022) Vol. 74, pp. 127082-127082
Open Access | Times Cited: 10
Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survival
Qiangwei Wang, Zhaoshi Bao, Tao Jiang, et al.
Cancer Immunology Immunotherapy (2021) Vol. 71, Iss. 4, pp. 953-966
Closed Access | Times Cited: 14
A new prognostic model for glioblastoma multiforme based on coagulation-related genes
Min Zhou, Yunbo Deng, Ya Fu, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 10, pp. 2898-2910
Open Access | Times Cited: 5
A cuproptosis-related gene DLAT as a novel prognostic marker and its relevance to immune infiltration in low-grade gliomas
Peng Gao, Huaixu Li, Qiao Yang, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32270-e32270
Open Access | Times Cited: 1
An immune-related gene pair signature predicts the prognosis and immunotherapeutic response in glioblastoma
Gang Wang, Yingchun Man, Kui Cao, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e39025-e39025
Open Access | Times Cited: 1
Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model
Enchong Zhang, Yijing Chen, Shurui Bao, et al.
Human Genomics (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
Chunyu Zhang, Lirui Guo, Zhongzhou Su, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 8
Molecular Characterization and Clinical Relevance of ANXA1 in Gliomas via 1,018 Chinese Cohort Patients
Zenghui Qian, Wenhua Fan, Fanlin Meng, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 8
Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma
Mohammed Ahmed, Isaias Hernández-Verdín, Franck Bielle, et al.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (2022) Vol. 50, Iss. 2, pp. 234-242
Open Access | Times Cited: 6
Comparative profiling of immune genes improves the prognoses of lower grade gliomas
Zhiliang Wang, Wen Cheng, Zheng Zhao, et al.
Cancer Biology and Medicine (2021) Vol. 19, Iss. 4, pp. 533-550
Open Access | Times Cited: 7
Ferroptosis-related gene MTF-1 as a novel prognostic biomarker in low-grade glioma and its correlation with immune infiltration
Huaixu Li, Xingliang Dai, Lv Zhou, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21159-e21159
Open Access | Times Cited: 2
Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma
Rongjie Zhang, Qian Li, Xiaoxiao Yu, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22083-e22083
Open Access | Times Cited: 2
Expression and prognostic value of CD80 and CD86 in the tumor microenvironment of newly diagnosed glioblastoma
Mohammed Ahmed, Isaias Hernández-Verdín, Maïté Verreault, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top